The introduction of Retatrutide in the nation is generating significant excitement within the obesity community. This innovative dual medication – targeting both GLP-1 and GIP – promises a potentially new strategy to tackling excess weight . Until recently, options have been restricted for many, and Retatrutide represents a hopeful prospect for